Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000020

President and CEO sold 2,000 shares at an average $14.72 ($29,435)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Doshi Dipal President and CEO 2023-03-27 Sale 10b5-1 −1,800 $14.63 $26,333 256,011 D
Doshi Dipal President and CEO 2023-03-27 Sale 10b5-1 −200 $15.51 $3,102 255,811 D
Open-market sales · 2,000 sh · avg $14.72 · $29,435
Loading xslF345X04/wf-form4_168012433661989.xml…